NewGenIvf Group Limited (NIVF)

NewGenIvf Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021
Cash & Equivalents	0.04	0.05	0.03
Cash & Cash Equivalents	0.04	0.05	0.03
Cash Growth	-22.83%	90.23%	-
Receivables	0	0	0.14
Inventory	0	0	0.04
Other Current Assets	0.01	0.04	0.61
Total Current Assets	0.05	0.09	0.82
Property, Plant & Equipment	0	0	0.59
Long-Term Investments	21.27	70.69	0
Total Long-Term Assets	21.27	70.69	0.59
Total Assets	21.32	70.79	1.41
Accounts Payable	0.62	0.05	0.05
Deferred Revenue	0	0	0.81
Current Debt	1.62	0	0.66
Other Current Liabilities	0	0	0.54
Total Current Liabilities	2.24	0.05	2.07
Long-Term Debt	0	0	0.26
Other Long-Term Liabilities	3.48	2.42	0
Total Long-Term Liabilities	3.48	2.42	0.26
Total Liabilities	5.72	2.47	2.33
Total Debt	1.62	0	0.93
Retained Earnings	-5.67	0.5	-1.05
Comprehensive Income	0	0	0.01
Shareholders' Equity	-5.67	0.98	-0.78
Net Cash / Debt	-1.58	0.05	-0.9
Net Cash Per Share	-0.29	0.01	-1.60
Working Capital	-2.19	0.04	-1.25
Book Value Per Share	-1.04	0.13	-1.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).